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Abstract
Background: The aim of the present study was to de-
termine whether regular exercise training (ET) is effec-
tive at promoting the mobilization of CPCs and im-
proving their functional activity in patients with re-
cently acquired myocardial infarction (STEMI). Regu-
lar physical training has been shown to improve my-
ocardial perfusion and cardiovascular function. This
may be related in part to a mobilization of bone mar-
row-derived circulating progenitor cells (CPCs) as well
as an enhanced vascularisation.
Methods: 37 patients with STEMI were randomly as-
signed to an ET group or a non-ET group (controls).
Two weeks after STEMI, three weeks after regular ET
and three months after ET, BNP levels, exercise
echocardiography and exercise spiroergometry were
evaluated. The number of CD34+/CD45+ and
CD133+/CD45+ CPCs was measured by flow cytome-
try analysis. The migration capacity of the CPCs was
determined with a boyden chamber and the clono-
genic capacity by CFU-assay.
Results: In the ET-group the number and migration
capacity of CPCs increased significantly after regular
exercise training. The BNP level decreased significant-
ly from 121 ± 94 to 75 ± 47 pg/ml (p<0.001) after the
ET period, the left ventricular ejection fraction raised
in parallel at peak exercise, and the cardiorespiratory
condition improved as demonstrated by an increase of
VO2max (from 1641 ± 522 to 1842 ± 724 ml/min,
p<0.02). These three effects persist till three months
after the ET period.
Conclusions: Regular physical activity appears to pre-
dispose the mobilization and enhanced functional ac-
tivity of CPCs, a phenomenon which might lead to an
improved cardiac function in patients with recently ac-
quired acute myocardial infarction.
Key words: Exercise training, Cytokines, Progenitor
Cells, Myocardial Infarction, Rehabilitation
INTRODUCTION
Regular physical training reduces the incidence of car-
diovascular events such as coronary heart disease, re-
infarction and cardiovascular mortality [1-4]. In addi-
tion to a reduction of cardiovascular risk factors such
as hypertension, diabetes mellitus and obesity, there is
also an increased regression of coronary stenosis.
Clinical studies have shown that physical training im-
proves myocardial perfusion and cardiovascular func-
tion in coronary artery disease [5, 6]. This might be re-
lated to a correction of endothelial dysfunction as well
as a promotion of antiinflammatory mechanisms [7].
The enhanced expression of eNOS and VEGF (vas-
cular endothelial growth factor) might improve the
mobilization of bone marrow-derived circulating
progenitor cells (CPCs) into peripheral blood and en-
hance the process of vasculogenesis [8-10]. Tissue is-
chemia was found to mobilize bone marrow-derived
CPCs into the peripheral blood and contribute to neo-
vascularisation in an animal model [11]. Human bone
marrow-derived CPCs significantly increase in patients
with acute myocardial infarction [12] and are able to
differentiate into cardiac myocytes, endothelial cells
and smooth muscle cells [13].
In coronary artery disease, however, the quantity
and function of CPCs are reduced, a phenomenon
that might depend on various cardiovascular risk fac-
tors such as age, gender, smoking, diabetes mellitus
and hypertension. Vasa et al. were able to demonstrate
a reduced amount of blood-derived CPCs in the pe-
ripheral blood of patients with coronary artery disease
in a manner that depended on the number of cardio-
vascular risk factors [14].
Despite the reduced quantity and restricted func-
tionality of CPCs, Hambrecht and coworkers found
that regular exercise training in patients with chronic
coronary artery disease can improve cardiac function.
An enhanced mobilization of progenitor cells has also
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Heinrich-Heine University of Düsseldorf, Germanybeen revealed following repeated exercise induced my-
ocardial ischemia, as well as an enhanced expression of
angiogenetic cytokines such as VEGF. This increases
the mobilisation of progenitor cells from the bone
marrow into the peripheral blood and probably leads
on the one hand to an intensified repair of vascular le-
sions in the coronary vasculature and on the other
hand to a neovascularisation within the heart muscle
[15].
The aim of our prospective study was to investigate
the effect of regular exercise training over three weeks
(rehabilitation program) on physical capacity, cardiac
performance and the mobilisation and function of
CPCs in patients with an acute myocardial infarction
(STEMI). For this purpose we determined the quantity
and function of CPCs in peripheral blood isolated
from STEMI patients at three different time points:
(t0) bevor intervention (2 weeks after acute myocardial
infarction) (t1) three weeks after intervention start
(five weeks after acute myocardial infarction) and (t2)
three months after rehabilitation (17 weeks after acute
myocardial infarction).
PATIENTS AND METHODS
Study protocol: Patients with a documented ST-eleva-
tion myocardial infarction (STEMI), onset of pain up
to 12 h, a left ventricular ejection fraction below
<60% and under the age of 75 years were enrolled in
this prospective study between February 2005 and Au-
gust 2006. Exclusion criteria included STEMI, signifi-
cant valvular heart disease, cardiogenic shock, renal
failure, anemia, orthopedics or other conditions that
prohibited participation in the exercise training. None
of the patients had a history of myocardial infarction.
All patients were treated immediately during the
acute phase of the infarction with aspirin, clopido-
grel and tirofiban. Subsequently coronary angio-
graphy was performed and the occluded infarct-relat-
ed coronary artery was recanalized. One week after
myocardial infarction all patients were randomly as-
signed to the exercise or non-exercise training group
(Fig. 1). For therapeutic reasons more patients were
randomized to the exercise training group (rehabilita-
tion) and so we chose a 2:1 randomization. At dis-
charge all patients received aspirin, clopidogrel, an-
giotensin-converting enzyme inhibitors or angio-
tensin-1 receptor antagonists, beta-blockers and
statins.
Follow-up visits were performed at 2 weeks (t0),
five weeks (t1) and 17 weeks (t2) and included clinical
status, laboratory examinations, ECG, exercise echo-
cardiography, spiroergometry, adverse events and
medications. The protocol for this study was approved
by the local Ethics Committee of the Heinrich- Heine
University in Düsseldorf.
Study objectives: The primary end points were changes
of global cardiac function using exercise echocardiog-
raphy from t0 (2 weeks after acute PCI) to t1 and t2
(five and 17 weeks) of follow-up. Global function was
determined by left ventricular ejection fraction (EF).
Secondary end points comprised changes of oxygen
consumption per unit time (VO2) using spiroergome-
t r yf r o mt 0 (2 weeks after acute AMI) to five and 17
weeks of follow-up. Changes of mobilized stem cells
(CD34/CD45+, CD133/CD45+), changes of migra-
tion capacity of the mononuclear cells and changes
of their clonogenic potential (CFU-assays) were ana-
lyzed.
EUROPEAN JOURNAL OF MEDICAL RESEARCH 394 September 1, 2009
Fig. 1. Enrollment and outcomes.Maximal exercise training test: A maximal exercise
training (ET) test was performed on a calibrated, elec-
tronically braked bicycle ergometer in an upright posi-
tion. It was performed once daily, on five days a week,
and for three weeks in total (15 times maximal exercise
training, Fig. 2).
According to Gysan et al. and Schönstedt et al., we
chose an ambulatory shortterm endurance training,
demonstrating good compliance by the patients and a
beneficial outcome [16, 17]. ECG tracing and blood
pressure readings were obtained every two minutes.
Workload was increased progressively every 2 minutes
at steps of 25 W, beginning at 25 W. Myocardial is-
chemia was confirmed by the presence of typical angi-
na pectoris or a significant exercise-induced ST-seg-
ment depression (>0.1 mV descending or horizontal).
Exercise was terminated when patients experienced
progressive chest pain, physical exhaustion, or when a
3-mm horizontal ST-segment depression was reached.
Exercise echocardiography: Echocardiographic images
were obtained in the parasternal long- and short axis,
and apical 2- and 4-chamber views using commercially
available equipment with a 2.5-MHz transducer rate of
30 frames/s. These images were recorded in quad-
screen cine loop format before and within 90 seconds
after treadmill exercise testing. Enddiastolic and end-
systolic diameter of the left ventricle at rest and after
exercise was visually interpreted by the consensus of
at least two experienced physician echocardiographers
unaware of the results of the left ventricular an-
giogram and the coronary angiography. The digital
quadscreen cine loop format was reviewed for analysis
of left ventricular function which was assessed by cal-
culation of the enddiastolic and endsystolic volumes
(Simpson formula).
Bicycle spiroergometry: After resting for 5 minutes, the
patients had their arterial blood pressure measured at
the right brachial artery using a sphygmomanometer.
A 12-lead electrocardiogram was recorded, and resting
heart rate (HR) was calculated from the R-R interval.
Each subject underwent maximal exercise testing on a
computer-driven bicycle ergometer using a ramp pro-
tocol starting at 50 W, with gradual increases of 25 W
every 2 minutes. During the test, patients worn a tight-
fitting face mask connected to an Oxycon Pro spirom-
eter. Oxygen consumption per unit time (VO2), car-
bon dioxide production (VCO2), and minute ventila-
tion were measured on a breath-by-breath basis. Sub-
jects were exercised to their self-determined maximal
capacity or until the physician stopped the test because
of symptoms such as chest pain or dizziness, poten-
tially dangerous arrhythmias or ST-segment deviations,
or marked systolic hypotension or hypertension. A
respiratory exchange ratio (VCO2/VO2)> 1w a st a k e n
to indicate maximal effort. Maximum oxygen con-
sumption was defined as the highest VO2 obtained at
the end of the test and is expressed in ml/min and
ml/min per kg.
Collection of venous blood samples: On the day before
the exercise training program starts (t0), one day after
the exercise training program ends (t1 = three weeks,
15 times exercise training tests) and three months after
the exercise training program (t2) venous blood sam-
ples were taken in the morning from fasting patients.
FACS analysis, isolations of circulating progenitor
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Fig. 2. Flow chart of the prospective controled clinical study. AMI, acute myocardial infarction.cells for migration and colony-forming-unit assay were
performed in all samples.
From the control patients with no exercise training
venous blood samples were also taken at matched time
points (Fig. 2).
Measurement of brain natriuretic peptide (BNP) in pe-
ripheral blood: In order to determine BNP levels, pe-
ripheral blood was taken at the same three time points
as descriped above. Whole blood samples were used
from all patients and BNP was measured using Triage-
Meter Plus (Biosite).
Isolation and cultivation of circulating progenitor cells:
20 ml peripheral venous blood was taken from each
patient at the three time points, as described above.
Blood was taken using a BD Vacutainer CPTTM sys-
tem containing a citrate anticoagulant with Ficoll Hy-
paque density fluid and a polyester gel barrier. Blood
samples were centrifugated for 20 min. at 3.000 rpm
(rounds per minute) at room temperature. The
mononuclear cells (MNCs) were resuspended by in-
verting the tube and the entire content above the gel
was transferred into a separate tube. After adding
phosphate buffered saline (PBS) the MNCs were cen-
trifugated for 10 min. with 2.300 rpm. Afterwards am-
monium chloride was added for 10 min. to accomplish
the lysis of all red blood cells. After two washing steps
with PBS mononuclear cells were resuspended in 1ml
EBM2-medium (Cell systems). The cell number was
determined in a Neubauer chamber.
Flow cytometry analysis: Two colour flow cytometry
assays were performed using an EPICS XL flow cy-
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lating progenitor cells, in
patients with acute my-
ocardial infarction.tometer (Beckman Coulter / Immunotech, Roissy
CDG, France) and Expo 32 data acquisition software
(Beckman Coulter / Immunotech). The instrument
was calibrated using beads (Beckman Coulter / Im-
munotech) according to the manufacturer´s instruc-
tions. For erythrocyte lysis, peripheral blood samples
were diluted in 15 ml bicarbonatebuffered ammonium
chloride solution (0.15M NH4CL, 0.01M NaHCO3,
1.0mM EDTA) for 15 minutes at room temperature.
The cells were centrifuged and resuspended in 500µl
pH 7.2 phosphate-buffered saline (PBS) (lyse-no-
wash, technique). In brief, 100µl of white-blood cell
sample were incubated with 10µl of FITC-conjugated
anti- CD45 (BD) and 10µl of phyocerythrin (PE)-con-
jugated anti-CD34 (BD) or anti-CD133 (BD) for 20
minutes at 4°C. All experiments included samples in-
cubated with an isotype control PE-labelled IgG1
(Beckman Coulter) as a negative control for nonspe-
cific binding. All samples were run in duplicate. Sam-
ples were stored on ice in the dark and analyzed within
two hours. The ISHAGE sequential gating strategy[18]
exploits the fact that blast cells can be identified from
their dim CD45 expression and low sidescatter
(SSC)[19]. Figure 3 illustrates an example of our ex-
periments using the gating strategy for CD34 analysis
(Fig. 3a-f).
Migration assay: Analysis of cell migration was per-
formed by seeding 1x106 MNCs per ml in the top
compartment of a boyden chamber (Fig. 4). The bot-
tom compartment contained either only EBM-2 medi-
um (supplemented with 0.1% BSA) or 100ng/ml stro-
mal cell derived factor-1 (SDF-1) or 200ng/ml VEGF
(vascular endothelial growth factor) in EBM2-medium
(supplemented with 0.1% BSA). Cells were allowed to
migrate for 24h at 37°C in humidified atmosphere.
The migrated cells were stained using a Diff-Quick
Staining Kit (Dade Behringer) and then counted by
two independent investigators.
Colony-forming unit assay: 1x1 0 5 MNCs per ml were
seeded in Methocult GF H4434 (Stemcell Technolo-
gies). Culture dishes were seeded with 1 ml cell sus-
pension and then incubated at 37°C in 5% CO2.
Colony-forming-unit erythroid (CFU-E) and CFU-
granulocyte/ macrophage (CFU-GM) were evaluated
14 days after seeding, using an inverted microscope.
The different clusters in the CFU assays were distin-
guished by their characteristic morphology and illumi-
nation by using an inverted microscope. No staining
or immunostaining was performed. CFU-eryhtroid
clusters showed small clusters and emitted a red to
brownish colour, whereas CFU-granulocyte/macro-
phage clusters presented flat colonies consisting of
translucent cells. CFU assays were quantified by count-
ing the clusters by two independent investigators.
Statistics: Variables are presented as means ± standard
deviation (SD), depicted in the text and figures. Cate-
gorical variables were compared with use of the chi-
square test or Fischer´s exact test. Statistical compar-
isons between initial and follow-up data were per-
formed in a nonparametric paired fashion using the
Wilcoxon signed-rank test. The nonparametric Mann-
Whitney U test was used for intergroup comparisons.
Statistical significance was assumed if p was < 0.05.
All probability values are 2-tailed. Statistical analysis
was performed using SPSS (version 12.0).
RESULTS
Patient characteristics: The baseline characteristics
were comparable in both groups (Table 1). All patients
suffered from an occlusion (Thrombolysis in Myocar-
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Fig. 4. Representative photos of a migration assay from an AMI patient with exercise training; before exercise training (t0), af-
ter exercise training (t1) and 3 months after exercise training (t2). Cells were evaluated 24 h after seeding 3 x 106 MNCs per ml
in the upper compartiment of a boyden chamber. The assay showed a significant increase of migrated cells after the exercise
training.dial Infarction (TIMI) flow grade 0/1 of 1 coronary
artery resulting in extensive myocardial infarctions.
Percutaneous coronary intervention was successfully
achieved in all patients resulting in TIMI flow grad
2/3. There was no significant difference between the
exercise training group and the control group regar-
ding cardiovascular risk factors, use of glycoprotein
IIb/IIIa antagonists and current medication. 25 pa-
tients were randomly assigned to the exercise training
group and 12 patients to the control group with no
physical training.
Effects of exercise training on clinical parameters and
BNP-levels in patients with STEMI: Patients in the
exercise training group showed a significant improve-
ment in their clinical condition after the exercise train-
ing test and three months later, as assessed by the
NYHA classification (New York Heart Association).
Furthermore, the BNP-level in peripheral blood de-
creased significantly after the ET-program from 121
± 94 to 75 ± 47 pg/ml (p<0.001) and remained re-
duced three months thereafter at 54 ± 42pg/ml
(Table 2). There were no significant changes in the
non-exercise control group. In the exercise echocar-
diography we found no difference in the left ventricu-
lar ejection fraction (EF) at rest in either group over
the investigated time, but at peak exercise the left ven-
tricular ejection fraction increased after the three
week–long exercise training program from 57 ± 14 to
60 ± 14%, and compared to the EF at rest (49 ±
12%), the peak EF (60 ± 14%) was significantly in-
creased (p = 0.031). In the spiroergometry, VO2max
increased significantly only in the ET-group from
1641 ± 522 to 1842 ± 724, p = 0.017 (baseline to af-
ter exercise training) and remained stable for the three
months thereafter.
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Table 1. Characteristics of patients.
Exercise Training after AMI Control- Patients with AMI p
Characteristics
N o .o fp a t i e n t s 2 5 1 2 n . s .
Gender m/w 21/4 7/5 n.s.
Age (yrs) 60 ± 9 63 ± 10 n.s.
Body-Mass Index (kg/m2) 27.30 ± 2.43 27.4 ± 3.94 n.s.
NYHA-classification 2.64 ± 0.57 2.75 ± 0.62 n.s.
I/II/III/IV 0/10/14/1 0/4/7/1
BNP level, pg/ml 121 ± 94 127 ± 78 n.s.
Coronary angiography
No. of coronary vessel disease 2.16 ± 0.83 2.5 ± 0.71 n.s.
1/2/3-c o r o n a r yv e s s e ld i s e a s e 7 /8/1 0 2/3/7
Infarct-related coronary vessel
L A D / L C X / R C A 1 0/7/8 5/3/4
No. of patients with stent, n (%) 24 (96) 12 (100)
Risk factors, n (%)
Smoking 10 (40) 5 (42) n.s.
Hypercholesterolemia 25 (100) 12 (100) n.s.
Diabetes mellitus 4 (16) 2 (17) n.s.
Hypertension 18 (72) 9 (75) n.s.
Positive family History 8 (32) 4 (33) n.s.
Medication, n (%)
Acetylsalicylacid 25 (100) 12 (100) n.s.
Clopidogrel 24 (96) 12 (100) n.s.
Beta-blocker 25 (100) 12 (100) n.s.
ACE-inhibitor or AT-1 antagonist 25 (100) 11 (90) n.s.
Statin 25 (100) 12 (100) n.s.
Labaratory parameters
CPK [U/L] 1196 ± 1463 1002 ± 1099 n.s.
CPK-MB (U/L) 189 ± 259 136 ± 219 n.s.
Troponin I (ng/ml) 21.5 ± 15.3 12.4 ± 9.5 n.s.
LDH (U/L) 545 ± 551 319 ± 164 n.s.
CRP (mg/dl) 5.28 ± 7.53 3.98 ± 5.41 n.s.The NYHA classification showed a significant im-
provement at five weeks and 17 weeks of follow-up in
the exercise training compared to the controls. BNP
demonstrated a relevant decrease at 17 weeks of fol-
low-up when both groups were compared. Further,
oxygen consumption per unit time per kg (VO2/ kg)
was slightly increased in the exercise training group
compared to the controls.
Effects of regular exercise training on circulating prog-
enitor cells: FACS-analysis showed that a symptom-
limited (ischemic) exercise training led to a significant
a n dt i m e – d e p e n d e n ti n c r e a s ef r o mt 0 (2 weeks after
acute AMI) to five weeks of follow-up in the
CD45+/CD34+ CPC-fraction from 257 ± 102 to 302
± 128 cells per 1 million MNCs (p = 0.022) and in the
CD45+/CD133+ CPC-fraction from 64 ± 26 to 88 ±
46 cells per 1 million MNCs (p = 0.023). 17 weeks of
follow-up, the number of CD45+/CD34+ CPCs de-
creased to 269 ± 117 cells per 1 million MNCs and the
number of CD45+/CD133+ CPCs decreased to 68 ±
32 cells per 1 million MNCs, reaching nearly the level
of onset measurement. In the nonexercise training
group the number of CPCs remained stable from t0
(two weeks after acute AMI) to five weeks and 17
weeks of follow-up. The number of CD45+/CD34+
cells counted 275 ± 68 cells per 1 million MNCs at t0,
254 ± 66 cells per 1 million MNCs five weeks of fol-
l o w - u pa n d2 6 8±6 9c e l l sp e r1m i l l i o nM N C s1 7
weeks of follow-up (Fig. 5 a and Table 3). The number
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Table 2. Response to exercise training and traditionaly rehabilitation in patients with STEMI evaluated by ergometry, exercise
echogardiography, exercise spiroergometry and BNP (brain natriuretic peptide).
Clinical status t0 t1 p+ t2 p# p§
NYHA-classification
exercise training 2.64 ± 0.57 1.32 ± 0.48 <0.001 1.52 ± 0.51 0.096 <0.001
controls 2.75 ± 0.62 2.25 ± 0.62 0.083 2.42 ± 0.52 n.s. n.s.
p n.s. <0.001 <0.001
BNP, pg/ml
exercise training 121 ± 94 75 ± 47 <0.001 54 ± 42 <0.001 <0.001
controls 127 ± 78 111 ± 80 n.s. 92 ± 63 n.s. n.s.
p n.s. n.s. 0.080
Ergometry
max. workload, watt
exercise training 101 ± 33 137 ± 53 <0.001
controls - -
p- -
Duration of exercise, min




EF at rest, %
exercise training 46 ± 12 49 ± 12 0.028 49 ± 11 n.s. 0.009
controls 48 ± 13 49 ± 16 n.s. 49 ± 12 n.s. n.s.
p n.s. n.s. n.s.
EF at peak exercise, %
exercise training 57 ± 14 60 ± 14 0.031 60 ± 15 n.s. 0.020
controls 57 ± 6 58 ± 7 n.s. 59 ± 8 n.s. n.s.
p n.s. n.s. n.s.
Exercise spiroergometry
max. workload, watt
exercise training 123 ± 47 140 ± 53 0.004 137 ± 52 n.s. 0.011
controls 125 ± 33 122 ± 41 n.s. 131 ± 44 n.s. n.s.
p n.s. n.s. n.s.
VO2max, ml/min
exercise training 1641 ± 522 1842 ± 724 0.017 1855 ± 695 n.s. 0.012
controls 1389 ± 547 1439 ± 465 n.s. 1851 ± 429 0.050 n.s.
p n.s. n.s. n.s.
VO2max/kg, ml/min/kg
exercise training 20.0 ± 4.3 22.5 ± 6.5 0.015 22.9 ± 6.6 n.s. 0.012
controls 17.6 ± 5.6 17.3 ± 4.5 n.s. 21.7 ± 5.0 0.093 n.s.
p n.s. 0.096 n.s.
EF = left ventriculare ejection fraction; VO2max = maximum oxygen consumption; BNP = brain natriuretic peptide; Values are
mean ± SD. p+ =t 0 vs. t1 ;p # =t 1 vs. t2;p § =t 0 vs. t2of CD45+/CD133+ cells was 73 ± 22, five weeks of
follow-up 58 ± 19 and 17 weeks of follow-up 72 ± 23
cells per 1 million MNCs. In the exercisetraining group,
the CD45+/CD133+ CPCs was slightly increased at
five weeks of follow-up (after the physical training)
compared to the controls (Fig. 5 b and Table 3).
Effects of regular exercise training on CPC function: In
order to assess the influence of regular exercise train-
ing on CPC function, the migration capacity of the
CPCs was analyzed. Regular exercise training in pa-
tients with STEMI led to a significant enhancement of
CPCs migration capacity after the three weeks lasting
training program from 113 ± 12 to 199 ± 57% (SDF-
1, in relation to control cells without cytokine,
p<0.001), and from 121 ± 19% to 242 ± 95% (VEGF,
in relation to control cells without cytokine, p<0.001),
although this phenomenon had vanished by three
months thereafter (Fig. 4 and 6 a, b). The CPCs migra-
tion capacity was significantly increased after the phys-
ical training (t1) in the exercise training group com-
pared to the controls.
The improved ability of the CPCs to migrate in the
exercise training group was accompanied by a stable
number of colonies, as demonstrated by CFU-ery-
throid and CFU -granulocyte/ macrophage. In the
non-exercise group after STEMI, the migration capac-
ity revealed no increase over the investigated time,
whereas the number of colonies in the clonogenic as-
says declined continuously after acute myocardial in-
farction from 23 ± 16 colonies before ET to 7 ± 7
colonies three months later in the CFU-GM assay and
significantly from 84 ± 51 colonies before ET to 26 ±
29 colonies three months later in the CFU-E assay
(Table 3).
DISCUSSION
In this prospective clinical trail, we assessed the effects
of regular exercise training in patients with STEMI on
clinical parameters (including BNP-level) and on the
quantity and quality of CPCs. In patients with STEMI,
regular symptom-limited exercise training over three
weeks was able to (i) improve the clinical condition
(NYHA-classification), (ii) increase the left ventricular
ejection fraction at peak exercise, (iii) improve the car-
diovascular capacity (exercise spiroergometry) and (iv)
enhance the mobilization of blood-derived circulating
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Table 3. Response to exercise training and traditionaly rehabilitation in patients with STEMI evaluated by ergometry, exercise
echogardiography, exercise spiroergometry and BNP (brain natriuretic peptide).
t0 t1 p+ t2 p# p§
Flow cytometry analysis
CD45+ /CD34+ cells, n
exercise training 257 ± 102 302 ± 128 0.022 269 ± 117 n.s. n.s.
controls 275 ± 68 254 ± 66 n.s. 268 ± 69 n.s. n.s.
p n.s. n.s. n.s.
CD45+ /CD133+ cells, n
exercise training 64 ± 26 88 ± 46 0.023 68 ± 32 0.018 n.s.
controls 73 ± 22 58 ± 19 0.075 72 ± 23 n.s. n.s.
p n.s. 0.060 n.s.
Migration capacity
C Cytokine SDF-1, %
exercise training 113 ± 12 199 ± 57 <0.001 130 ± 37 <0.001 0.055
controls 127 ± 30 128 ± 41 n.s. 112 ± 10 n.s. n.s.
p n.s. <0.001 n.s.
Cytokine VEGF, %
exercise training 121 ± 19 242 ± 95 <0.001 134 ± 44 <0.001 n.s.
controls  142 ± 45 134 ± 44 n.s. 110 ± 12 0.060 n.s.
p n.s. <0.001 n.s.
Clonogenic potential
CFU-erythroid, n
exercise training 50 ± 33 46 ± 33 n.s. 39 ± 28 n.s. n.s.
controls 84 ± 51 52 ± 53 0.058 26 ± 29 n.s. 0.009
p 0.065 n.s. n.s.
CFU-granulo./macrophage, n
exercise training 13 ± 9 12 ± 7 n.s. 18 ± 15 n.s. n.s.
controls 23 ± 16 14 ± 12 n.s. 7 ± 7 n.s. 0.092
p 0.095 n.s. 0.027
Data  are  shown as mean ± SD.Amount of CD45+/CD34+ cells and CD45+/CD133+ cells are expressed as cells per 1x 106
MNCs. Migration capacity is expressed in % as relation of migrated cells toward the cytokines SDF-1 and VEGF in comparison
to the migrated cells without chemokine. Colony forming unit is expressed as number of colonies per 1x 105 seeded MNCs.
Values are mean ± SD. p+ = t0 vs. t1 ; p# = t1 vs. t2; p§ = t0 vs. t2EUROPEAN JOURNAL OF MEDICAL RESEARCH September 1, 2009 401
Fig. 5. Quantitative evaluation of CD45+/CD34+
cells (Fig. 5a) and CD45+/CD133+ cells (Fig. 5b) by
flow cytometry analysis. Patients with exercise train-
ing shows a temporarily increase of the CPCs be-
tween t0 and t1. In the control group (patients with
traditional rehabilitation) were no differences ob-
served. Values are expressed as total numbers of
CD45+/CD34+ cells, respectively  CD45+/CD133+
cells, related to 1x 106 MNCs. Values are mean ± SD.
t0, before exercise training; t1, after exercise training;
t2, 3 months after exercise training.
Fig. 6. Quantitative evaluation of migration capacity
of CPCs in boyden chamber. Relative amount of mi-
grated cells to SDF-1 (a) and VEGF (b) in compari-
son to cells without chemokines in blood samples of
patients with STEMI and exercise training and pa-
tients with STEMI and traditional rehabilitation,
blood samples were analyzed at 3 different time
points. Values are expressed as % of migrated cells
without chemokine. Values are mean ± SD.progenitor cells from bone marrow into peripheral
blood, improve the migratory capacity and stabilize
the clonogenic potential of the CPCs.
These data imply that regular symptom-limited ex-
ercise training suffices to increase the quantity and
function of circulating progenitor cells. This finding is
consistent with the hypothesis that an ischemic stimu-
lus may trigger the release of CPCs from the bone
marrow into the peripheral blood.
The development of new vessels in response to tis-
sue ischemia constitutes a natural reaction intended to
maintain adequate perfusion. This process was for-
merly believed to result from the sprouting of preex-
isting arteries rather than the formation of entirely
new vessels. However, this traditional concept was
shattered by the observations that operative hind limb
ischemia induces a significant increase in circulating
bone marrow-derived EPCs and that heterologous,
homologous or autologous transplanted EPCs be-
come incorporated into neovascularisation foci [9, 11,
20, 21]. Such results from animal models have also
been confirmed in clinical settings. An increase in
EPCs and a possible participation in neovascularisa-
tion have both been demonstrated in patients with
acute myocardial infarction [12, 22]. Clinical trials
studying the intracoronary transplantation of BM
stem / progenitor cells as well as BM-derived autolo-
gous circulating progenitor cells have also shown that
these cells have the potential to improve the function
of the myocardium after acute ischemic injury [23-27].
Nevertheless, many questions remain to be answered. 
Does a regular exercise training have any effect on
the number and function of circulating progenitor
cells after myocardial infarction?
Circulating progenitor cells as CD45+/CD34+ and
CD45+/CD133+ stem cells were investigated, both are
primitive bone marrow cells that have the capacity to
proliferate, migrate, and differentiate into various 
mature cell types [28, 29]. These bone marrow-derived
circulating progenitor cells express unique surface
markers, as CD34 and the early hematopoetic 
cell marker CD133 (AC133) [30, 31]. Tissue ischemia
was found to mobilize endothelial progenitor cells into
the peripheral blood and to contribute to neovasculari-
sation in an animal model [11]. In addition, human
BM-CPCs have been shown to be significantly in-
creased in patients after acute myocardial infarction
(AMI) [12] and to differentiate into cardiac myocytes,
endothelial cells and smooth muscle cells following
AMI [32]. Experimental studies suggested that 
BM-CPCs may contribute to the regeneration of in-
farcted myocardium [33] [34] and improve neovascu-
larization of ischaemic myocardium [35-38]. However,
the function of early haematopoietic stem cell marker
CD133 is still unknown. Using CD133 expression to
define a very early subset of progenitor cells, Peichev
et al. [31] isolated a CD133+ subpopulation of cells,
which were able to differentiate into mature endothe-
lial cells.
This present study is the first report showing that
regular symptom-limited exercise training is sufficient
to trigger a time-dependent increase in circulating
progenitor cells and their function in patients who had
previously suffered an acute myocardial infarction.
Regular exercise training leds to a significant increase
in circulating progenitor cells (CD34+ cells, respective-
ly CD133+ cells). This augmentation in CPCs is com-
parable with the response to other therapeutic stimuli
that increase CPCs, such as a four week long statin
therapy [39] or VEGF-gene therapy [10, 40].
The transient increase in circulating progenitor cells
after regular symptom-limited (ischemic and /or subis-
chemic) exercise training reached a maximum after the
exercise training, but did not persist up until three
months after the regular exercise training. This finding
extends our knowledge about the long-term effect of
rehabilitation training programs on the changes in cir-
culating progenitor cells. Laufs and colleagues de-
scribed a significant increase in circulating progenitor
cells after a 4 week, non-controlled rehabilitation
training program in patients with stable coronary
artery disease without exercise-induced ischemia [41].
In that trial it was speculated that asymptomatic tissue
ischemia leads to an increase in vasculogenic cy-
tokines, in the same way that symptomatic tissue is-
chemia does.
It is important to note here that an increase in
CPCs is associated with significant increases in both
CD34+ cells and CD133+ cells. This observation sug-
gests that the response of the bone marrow to
episodes of ischemia is not restricted to a specific cell
type release, but is much rather a complex reaction
where various progenitor cell populations and leuko-
cyte subtypes become involved.
Not only is the quantity of circulation progenitor
cells is altered, but their function is also modified by
ischemic conditions and therapeutic interventions [42].
Migration of CPCs to ischemic tissue is believed to
play a major role in the growth of new bloodvessels.
Migration is essential for the ability of stem / progeni-
tor cells to invade ischemic tissue. SDF-1 and VEGF
are both profoundly upregulated in hypoxic tissue and
may therefore represent physiologically relevant
chemoattractants for the recruitment of circulating
progenitor cells to ischemia sites [43, 44]. Indeed, in-
tramuscular injection of SDF-1 has recently been
shown to increase the number of incorporated en-
dothelial progenitor cells and to improve neovasculari-
sation in vivo [45].
In the present study, a migration assay was per-
formed to investigate the ability of CPCs to migrate
into ischemic tissue. The Boyden Chamber simulates
the capacity of circulating progenitor cells to migrate
to a chemotaxin such as VEGF or SDF-1 in patients
with STEMI. This finding is consistent with the no-
tion that both VEGF and SDF-1, which were differen-
tially regulated during ischemic training, are involved
primarily in altering the functional characteristics of
CPCs. The result of the phenotypic analysis was not in
accordance with a larger number of hematopoietic
colonies obtained from peripheral blood mononuclear
cells of patients with acute myocardial infarction per-
forming regular exercise training, instead the number
of the colonies remained stable over the investigated
time. In patients with acute myocardial infarction per-
forming no rehabilitation a continuous decrease in the
number of hematopoietic colonies was assessed. This
is in accordance with Massa et al.[46], demonstrating a
EUROPEAN JOURNAL OF MEDICAL RESEARCH 402 September 1, 2009continuous decline at 24 hours and 7 days with respect
to admission with acute myocardial infarction. We sug-
gest that immediately after acute myocardial infarction
the number of colonies goes up, but then decline con-
tinuously. If regular exercise training (rehabilitation) is
performed after acute myocardial infarction the de-
cline of the number of colonies is delayed or even
prevented. Improvement of clinical and hemodynamic
parameters after regular exercise-training ET improves
the quality of life in both men and women with mod-
erate, chronic heart failure [47]. In a recent meta analy-
sis by Smart and Marwick looking at patients with sta-
ble heart failure, ET was found to be associated with a
reduction in cardiorespiratory symptoms and an im-
proved functional capacity [48]. We have shown in our
study an improved clinical condition (depicted in
NYHA classification) and a decreased BNP-level di-
rectly after exercise training and three months there-
after.
Some clinical studies suggest that ET improves car-
diac output by consistently increasing exercise capacity
in heart failure [49] [50]. Likewise, we also found a sig-
nificantly improved exercise capacity in the ET group,
probably because of the increased left ventricular ejec-
tion fraction at peak exercise and the enhanced maxi-
mum oxygen uptake (VO2 max) after a regular three
week-long ET.
ET in chronic heart failure reduces catecholamines
and vascular peripheral resistance while modulating
heart rate variability and the baroreflex gain [51]. In a
multicentre, randomised controlled clinical study
(ELVD) in patients with a first Qwave myocardial in-
farction [52], regional wall motion abnormalities and
endsystolic volume both decreased 6 months after the
ET. In that study it was suggested that an enhanced
contractile performance predominantly contributed to
the improved left ventricular function in their patients
who showed an ejection fraction of below 40%.
Our findings show a significant increase in left ven-
tricular ejection fraction at peak exercise in the bicycle
echocardiography after ET, similar to the data of Gi-
annuzzi et al., but we did not find an increase in the
left ventricular ejection fraction at rest. This difference
may have arisen because of the lower left ventricular
ejection fraction and the longer exercise program peri-
od (6 months) that was evident in the ELVD study.
On the basis of the findings of Giannuzzi et al.
[52], it is tempting to speculate that regular exercise
training may decrease endsystolic volume and regional
wall motion abnormalities by bringing about beneficial
changes in the autonomic balance and / or baroreflex
gain. This is in line with an attenuation of the vaso-
constrictor influence (mainly due to reduced sympa-
thetic activity) and an increase in vagal tone [51]. 
Regular exercise training improved myocardial per-
fusion in stable coronary artery disease [53]. In acute
myocardial infarction, long-term exercise training im-
proved left ventricular ejection fraction evaluated by
radionuclide ventriculography [54]. Furthermore, early
post-infarction cardiac rehabilitation improved the
cardiorespiratory fitness, with direct measurement of
maximal oxygen uptake (VO2max) [55]. 
In the present study, we demonstrate an increased
exercise capacity, an improved cardiac function and a
better cardiorespiratory condition in patients with
acute myocardial infarction performing regular exer-
cise training. In an animal model physical training in-
creases endothelial progenitor cells, inhibits neointimal
formation and enhances angiogenesis [41]. One mech-
anism of repair by which physical training may im-
prove in human cardiac function after myocardial in-
farction, is considered to be the mobilization of bone
marrow-derived progenitor cells homing into the dam-
aged tissue area, where they induced neovascularisa-
tion [56] [57]. Homing of the progenitor cells can be
improved by the chemokine stromal cell-derived factor
1 (SDF-1), which is intrinsically produced by the my-
ocardium after myocardial infarction. As recently
shown, the intramyocardial delivery of SDF-1 increas-
es the homing of c-kit+ stem cells [58]. The beneficial
effect of regular exercise training on myocardial perfu-
sion has not been well established in humans. Howev-
er, increased myocardial perfusion was demonstrated
after symptom-limited exercise training after acute my-
ocardial infarction [59] [60]. Mechanisms that promote
enhanced myocardial perfusion include significant re-
lease of bone marrow-derived progenitor cells into
circulation, as observed in our study. In addition,
paracrine angiogenic factors, such as vascular endothe-
lial growth factor are released after physical training
and may increase neovascularisation in ischemic tissue
[41] [61]. Enhanced neovascularisation may serve as
one important mechanism facilitating reduction of in-
farct size after myocardial infarction.
In this first prospective clinical study, we were able
to confirm the efficacy of a regular three week-long
(15 times) symptom-limited (ischemia) exercise train-
ing in increasing both the cardiac function and num-
ber of CPCs amongst patients with STEMI. The fol-
lowing major conclusions can be drawn from our find-
ings: (i) local tissue ischemia induced by symptom-lim-
ited exercise training enhance the mobilization of re-
generative progenitor cells from bone marrow into pe-
ripheral blood, (ii) ischemia may be involved in the
regulation of the migration capacity of CPCs and (iii)
enhanced mobilization and increase migration capacity
of CPCs are associated with improved cardiac func-
tion and cardiorespiratory condition. Thus, early short
term exercise training has beneficial effects for the re-
habilitation of patients with STEMI.
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